5‐MeO‐DMT & THCV Vaporizer: What the Science Actually Says About Depression
Curious about a vaporizer combo of 5‐MeO‐DMT and THCV for depression? We break down the real research, the gaps, and why the idea is intriguing.
-
-
Short‐Term Study Finds Mushroom Blend May Reduce Stress and Improve Sleep – A 12‐Week RCT
A 12‐week RCT found a mushroom blend may lower anxiety, fatigue and improve sleep. What did the trial reveal about stress‐relief and biomarkers?
-
What Makes Meditation Calm and Hypnosis Automatic? A 2012 Study Shows the Role of Higher‐Order Awareness
A 2012 comparative study explains why meditation feels like deliberate focus while hypnosis can feel involuntary, highlighting the role of higher‐order awareness, executive function, and agency.
-
Psilocybin Therapy for Depression: What a Meta‐Analysis Reveals
Explore what a meta‐analysis of six trials says about psilocybin therapy for depression—benefits, side‐effects, and the limits of current evidence.
-
Ibogaine Therapy: What the Early Evidence Really Shows
Explore emerging evidence on ibogaine therapy for opioid cravings, PTSD, and depression. Learn about early study outcomes, safety concerns, and limits of the research.
-
Can Psychedelics Boost Social Flexibility in Autism? What the Evidence Shows
A deep dive into the emerging review on psychedelics for autism—what the data say, why neuroplasticity matters, and the ethical roadblocks ahead.
-
Altered States of Consciousness: 2026 Review of 25 Disciplines
A 2026 preprint reviews 25 disciplines of altered states, from meditation to psychedelics, and maps the brain mechanisms behind mind‐expanding practices.
-
When Australia’s GPs Became the First Gatekeepers of Legal Psychedelic Therapy
Australia’s historic down‐scheduling of psilocybin and MDMA lets GPs refer patients for psychedelic‐assisted psychotherapy. This article explains what the science shows, what it does not, and the practical steps doctors need to take.
-
Mushroom Blend Cut Anxiety Scores and Boosted Sleep in a Double‐Blind Trial
A double‐blind trial of a mushroom blend (Restake) showed reduced anxiety, fatigue and better sleep in 50 adults, with hormone shifts that hint at a physiological basis.
-
Can ADHD One Day Be Diagnosed Like a Broken Bone? New Paths from Dopamine to DNA
A deep dive into the latest ADHD roadmap—how dopamine, genetics and brain imaging could finally give the disorder an objective test.
